Previous Close | 0.2600 |
Open | 0.2500 |
Bid | 0.2500 x 0 |
Ask | 0.2600 x 0 |
Day's Range | 0.2400 - 0.2600 |
52 Week Range | 0.1400 - 0.3500 |
Volume | |
Avg. Volume | 130,500 |
Market Cap | 65.346M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Dec 27, 2006 |
1y Target Est | N/A |
VANCOUVER, British Columbia, June 22, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) is pleased to announce that it has signed an agreement with Contract Manufacturing Organization (CMO) WuXi AppTec (“WuXi”), Shanghai, for the small-scale production of TFC-1326, a powerful active against the aging effects on skin. Years of groundbreaking research by Sirona’s team of scientists at TFChem has shown in preclinical studies that TFC-1326 has the potentia
VANCOUVER, British Columbia, June 20, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) is pleased to announce that Dr. Wolfgang Bieber will join Sirona Biochem’s Advisory Board and act as a consultant to the Board of Directors with immediate effect. Dr. Wolfgang Bieber brings to Sirona Biochem 30 years of experience from his career at BAYER AG, a global pharmaceutical and agrochemical company with sales of US$52 billion and more than 100,000 employees
VANCOUVER, British Columbia, June 15, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) is pleased to inform about several significant corporate changes currently in preparation: Now that Sirona Biochem has closed an exclusive global licencing agreement with Allergan Aesthetics, the next steps for sustainable and rapid growth of the company are initiated. The Board has begun a strategic review of every facet of the company including management, organiz